BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed MDWD catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:52cce0ef1a2085043b22@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:MDWD P3 readout (est.): VALUE
DESCRIPTION:A Double Blind Study Performed to Evaluate the Efficacy and the
  Safety of EscharEx in Debridement of VLU (VALUE)\nNCT06568627 | PHASE3 | 
 RECRUITING | sponsor: MediWound Ltd\nPrimary completion date (ESTIMATED)\;
  top-line results usually follow later.\nDate precision: month (shown on t
 he first day)\nTicker MDWD (confidence 0.9)\nSource: https://clinicaltrial
 s.gov/study/NCT06568627\nScheduling/reference data from public records\; d
 ates can move. Not investment\, legal or medical advice.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT06568627
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
